The Leukemia & Lymphoma Society Announces Winners of Visionaries of the Year Campaign

Approximately every nine minutes, someone in the U.S. dies from a blood cancer. Through The Leukemia & Lymphoma Society’s (LLS) Visionaries of the Year philanthropic competition, thousands of unstoppable go-getters across the U.S. are determined to change this alarming statistic. LLS announced recently, Gina Tronco of Albany, NY, was awarded the campaign’s prestigious title, “Visionary of the Year,” raising over $915,700 for LLS. For ten weeks, Visionaries of the Year candidates and their team members, 8,000 in total around the country, rallied their networks to raise critical funds for LLS’s…

Read More

The Leukemia & Lymphoma Society Announces “Visionaries of the Year” Campaigns to Advance Mission

The global leader in the fight against blood cancer, The Leukemia & Lymphoma Society (LLS), continues to reach new heights in enhancing its fundraising campaigns. Recently, LLS announced the evolution of its signature campaigns, Man & Woman of the Year and Students of Year. Focused on innovating participant experiences and embracing the unified resolve to create a better world – one without blood cancers – Man & Woman of the Year and Students of Year are transitioning nationwide in 152 markets to LLS Visionaries of the Year and LLS Student…

Read More

A $50 Million Initiative to Fuel the Next Generation of Cancer Research for Generations to Come

Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to find cures, and The Leukemia & Lymphoma Society (LLS) is marking the occasion with a reinvigorated focus on helping children with cancer live better, longer lives. LLS announced today it has more than doubled its funding of research focused specifically on childhood blood cancers, adding 20 new research grants valued at more than $13.8 million to its research portfolio in 2019.  With these new grants, LLS now has committed…

Read More

The Leukemia & Lymphoma Society (LLS) Is Driving Progress To Ease The Pain Of High Cancer Care Costs For Patients

The cost of cancer care continues to rise at an alarming rate and is projected to reach $173 billion by 2020, a 39 percent increase from a decade ago. A growing portion of these costs are being shifted to patients. As a result, some patients are delaying or even forgoing potentially lifesaving cancer treatment. The Leukemia & Lymphoma Society (LLS) calls on key healthcare stakeholders to make changes that would help offset these costs. While some important progress has been made to improve patients’ access to affordable, high-quality and stable…

Read More